SAM
DPLO

Senzar Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Senzar Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-445,200
Closed -$7.1M – 34
2017
Q1 		$7.1M Buy
+445,200
New +$6.42M 1.8% 21

Other funds holding DPLO

FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Senzar Asset Management's DPLO Position: Q2 2017 in Review

Senzar Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2017, closing a stake of 445,200 shares — an estimated $7.1M sold.

Senzar Asset Management first reported a position in DPLO in Q1 2017 and held it in 1 quarter. The position peaked at $7.1M in Q1 2017. 175 funds tracked by Wall St. Rank hold DPLO as of Q2 2017.

  • Senzar Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2017 after selling out during the quarter.
  • Senzar Asset Management sold 445,200 DIPLOMAT PHARMACY, INC. shares in Q2 2017, an estimated $7.1M.
  • Senzar Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2017 and held it in 1 quarter.
  • Senzar Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $7.1M in Q1 2017.
  • 175 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2017.

Based on Senzar Asset Management's 13F filing for Q2 2017, filed 11 Aug 2017.